Functional organ preservation for laryngeal cancer: Past, present and future

Japanese Journal of Clinical Oncology

Volumn 42, Issue 3, 2012, Pages 155-160

  Nakayama, Meijin ^a   Laccourreye, Ollivier ^b   Holsinger, F Christopher ^c   Okamoto, Makito ^a   Hayakawa, Kazushige ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoradiation; Chemoradiotherapy; Laryngeal function; Larynx preservation; Organ preservation; Partial laryngectomy; Supracricoid laryngectomy

Indexed keywords

CISPLATIN; COBALT 60; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; TAXANE DERIVATIVE;

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARBON DIOXIDE LASER; CHEMORADIOTHERAPY; COBALT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRICOHYOIDOEPIGLOTTOPEXY; CRICOHYOIDOPEXY; DRUG MEGADOSE; FUNCTIONAL STATUS; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LARYNGEAL PRESERVATION; LARYNGECTOMY; LARYNGOSCOPY; LARYNX CANCER; LARYNX SURGERY; LASER SURGERY; META ANALYSIS; ORGAN PRESERVATION; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALVAGE THERAPY; SURVIVAL RATE; TRANSORAL LASER MICROSURGERY; VIDEOLARYNGOSCOPY;

HUMANS; LARYNGEAL NEOPLASMS; OTOLARYNGOLOGY;

EID: 84857986036     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr190     Document Type: Article

References (42)

1. Terrell J, Fisher S, Wolf G. Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg 2011;124:964-71.
2. Piquet JC, Piquet JJ. Partial vertical laryngectomy in cancer of the larynx. Laryngoscope 1963;73:1351-69.
3. Ogura J, Dedo H. Glottic reconstruction following subtotal glottic- supraglottic laryngectomy. Laryngoscope 1965;75:865-78.
4. Hiroto I, Mitsuhashi S, Ichikawa A, Kurokawa H. Functional conservative surgery for laryngeal carcinoma-partial laryngectomy. Gan no Rinsho 1971;17:121-4 (in Japanese).
5. Majer H, Rieder A. Technique de laryngectomie permetant de conserver la permeabilite respiratoire. (La crico-hyoido-pexie). Ann Otolaryngol Chir Cervicofac 1959;76:677-83.
6. Laccourreye O, Salzer S, Brasnu D, Shen W, Laccourreye H, Weinstein G. Glottic carcinoma with a fixed true vocal cord-outcomes following chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg 1996;3:400-6.
7. Strong M, Jako G. Laser surgery in the larynx: early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol 1972;81:791-8.
8. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
9. Forastiere A, Goepfert H, Maor M, Pajak T, Webwe R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
10. Lambert L, Fortin B, Soulieres D, Guertin L, Coulonbe G, Charpentier G, et al. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding? Int J Radiation Oncology Biol Phys 2010;76:398-402.
11. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival. Trade-offs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981;2:982-7.
12. Laccourreye O, Malinvaud D, Holsinger F Ch, Consoli S, Menard M, Bonfils P. Trade-off between survival and laryngeal preservation in advanced laryngeal cancer: the otorhinolaryngology patient's perspective. Ann Otol Rhinol Laryngol 2012 (in press).
13. Gao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:427-35.
14. Yilmaz T, Hosal S, Ozyar E, Akyol F, Gursel B. Postoperative radiotherapy in advanced laryngeal cancer: effect on local and regional recurrence, distant metastasis and second primaries. J Laryngol Otol 2005;119:784-90.
15. Pfister D, Laurie S, Weinstein G, Mendenhall W, Adelstein D, Ang K, et al. American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24:3693-704.
16. Spector G, Session D, Chao C, Hanson J, Simpson J, Perez C. Management of stage II (T2N0M0) glottis carcinoma by radiotherapy and conservation surgery. Head Neck 1999;21:116-23.
17. Hayakawa K, Mitsuhashi N, Akimoto T, Maebashi K, Ishikawa H, Niibe H, et al. The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis. Laryngoscope 1996;106:1545-7.
18. Nakayama M, Hayakawa K, Okamoto M, Niibe Y, Ishiyama H, Shouko K. Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer. Jpn J Clin Oncol 2010;40:921-6.
19. Fu K, Pajak T, Trotti A, Jones C, Spencer S, Phillips T, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Head Neck 2000;48:7-16.
20. Daly M, Le Q, Jain A, Maxim P, Hsu A, Loo B, et al. Intensity-modulated radiotherapy for locally advanced cancers of larynx and hypopharynx. Head Neck 2011;33:103-11.
21. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As C, et al. Dysphasia and aspiration after chemoradiotherapy for head-and neck cancer: which anatomic structures are affected and can they spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-39.
22. Pignon J, Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92: 4-14.
23. Chen A, Halpern M. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007;133:1270-6.
24. Worden F, Moyer J, Lee J, Taylor J, Urba S, Eisbruch A, et al. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope 2009;119:1510-7.
25. Patel U, Howell L. Local response to chemoradiation in T4 larynx cancer with cartilage invasion. Laryngoscope 2010;121:106-10.
26. Cmelak A, Li S, Goldwasser M, Murphy B, Cannon M, Pinto H, et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative oncology group study E2399. J Clin Oncol 2007;25:3971-7.
27. Homma A, Inamura N, Oridate N, Suzuki S, Hatakeyama H, Mizumaschi T, et al. Concomitant weekly cisplatin and radiotherapy for head and neck cancer. Jpn J Clin Oncol 2011;41:980-6.
28. Kano S, Homma A, Oridate N, Suzuki F, Hatakeyama H, Mizumachi T, et al. Superselective arterial cisplatin infusion with concomitant radiotherapy for base of tongue cancer. Oral Oncol 2011;47:665-70.
29. Yoshizaki T, Kondo S, Wakisaka N, Murono S, Kitagawa N, Tsuji A, et al. Concurrent intra-arterial chemotherapy and radiotherapy for advanced laryngeal cancer. Ann Otol Rhinol Laryngol 2009;118: 172-8.
30. Machtay M, Moughan J, Trotti A, Graden A, Weber R, Cooper J, et al. Factor associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582-9.
31. Weber R, Berkey B, Forastiere A, Cooper J, Maor M, Goepfert H, et al. Outcome of salvage total laryngectomy following organ preservation therapy. Arch Otolaryngol Head Neck Surg 2003;129:44-9.
32. Nakayama M, Okamoto M, Seino Y, Miyamoto S, Matsuki T, Ogawa A. Delayed wound infection after supracricoid partial laryngectomy following failure of high dose radiation. Eur Arch Otorhinolaryngol 2011;268:273-9.
33. Hoffman H, Porter K, Karnell L, Cooper J, Weber r, Langer C, et al. Laryngeal cancer in the United States: changes in demographics, patterns of cure, and survival. Laryngoscope 2006;116(Suppl. 111):1-13.
34. Olsen K. Reexamining the treatment of advanced laryngeal cancer. Head Neck 2010;32:1-6.
35. Forastiere A. Larynx preservation and survival trends: should there be concern? Head Neck 2010;32:14-7.
36. 2-laser treatment of recurrent glottis carcinoma. Head Neck 2001;23:177-80.
37. Hinni M, Salassa A, Grant D, Pearson B, Hayden R, Martin A, et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007;133:1198-204.
38. Shiotani A, Tomifuji M, Araki K, Yamashita T. Transoral videolaryngoscopic surgery for en bloc resection of supraglottic and hypopharyngeal cancers. Otolaryngol Head Neck Surg 2011;144: 288-9.
39. Yiotakis J, Stavroulaki P, Nikolopoulos T, Manolopoulos L, Kandiloros D, Ferekidis E, et al. Partial laryngectomy after irradiation failure. Otolaryngol Head Neck Surg 2003;128:200-9.
40. Laccourreye O, Laccourreye L, Garcia D, Gutierrez-Fonseca R, Brasnu D, Weinstein G. Vertical partial laryngectomy versus supracricoid partial laryngectomy for selected carcinomas of the true cord classified as T2N0. Ann Otol Rhinol Laryngol 2000;109:965-71.
41. Holsinger C. Swing of the pendulum: optimizing functional outcomes in larynx cancer. Curr Oncol Rep 2008;10:170-5.
42. Holsinger C, Nussenbaum B, Nakayama M, Saraiya S, Sewnaik A, Ark N, et al. Current concept and new horizons in conservation laryngeal surgery: an important role of multidisciplinary care. Head Neck 2010;32:656-65.